Literature DB >> 23350613

A national network to advance the field of cancer and female sexuality.

Shari B Goldfarb1, Emily Abramsohn, Barbara L Andersen, Shirley R Baron, Jeanne Carter, Maura Dickler, Judith Florendo, Leslie Freeman, Katherine Githens, David Kushner, Jennifer A Makelarski, S Diane Yamada, Stacy Tessler Lindau.   

Abstract

INTRODUCTION: Understanding sexual health issues in cancer patients is integral to care for the continuously growing cancer survivor population. AIM: To create a national network of active clinicians and researchers focusing on the prevention and treatment of sexual problems in women and girls with cancer.
METHODS: Interdisciplinary teams from the University of Chicago and Memorial Sloan-Kettering Cancer Center jointly developed the mission for a national conference to convene clinicians and researchers in the field of cancer and female sexuality. The invitee list was developed by both institutions and further iterated through suggestions from invitees. The conference agenda focused on three high-priority topics under the guidance of a professional facilitator. Breakout groups were led by attendees recognized by collaborators as experts in those topics. Conference costs were shared by both institutions. MAIN OUTCOME MEASURE: Development of Scientific Working Groups (SWGs).
RESULTS: One hundred two clinicians and researchers were invited to attend the 1st National Conference on Cancer and Female Sexuality. Forty-three individuals from 20 different institutions across 14 states attended, including representation from eight National Cancer Institute (NCI)-funded cancer centers. Attendees included PhD researchers (N = 19), physicians (N = 16), and other healthcare professionals (N = 8). Breakout groups included (i) Defining key life course sexuality issues; (ii) Building a registry; and (iii) Implementing sexual health assessment. Breakout group summaries incorporated group consensus on key points and priorities. These generated six SWGs with volunteer leaders to accelerate future research and discovery: (i) Technology-based interventions; (ii) Basic science; (iii) Clinical trials; (iv) Registries; (v) Measurement; and (vi) Secondary data analysis. Most attendees volunteered for at least one SWG (N = 35), and many volunteered for two (N = 21).
CONCLUSION: This 1st National Conference demonstrated high motivation and broad participation to address research on cancer and female sexuality. Areas of need were identified, and SWGs established to help promote research in this field.
© 2013 International Society for Sexual Medicine.

Entities:  

Mesh:

Year:  2013        PMID: 23350613      PMCID: PMC3616746          DOI: 10.1111/jsm.12061

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  17 in total

1.  Life after breast cancer: understanding women's health-related quality of life and sexual functioning.

Authors:  P A Ganz; J H Rowland; K Desmond; B E Meyerowitz; G E Wyatt
Journal:  J Clin Oncol       Date:  1998-02       Impact factor: 44.544

2.  Detecting alcoholism. The CAGE questionnaire.

Authors:  J A Ewing
Journal:  JAMA       Date:  1984-10-12       Impact factor: 56.272

3.  Assessing gynecologic and breast cancer survivors' sexual health care needs.

Authors:  Emily K Hill; Stacey Sandbo; Emily Abramsohn; Jennifer Makelarski; Kristen Wroblewski; Emily R Wenrich; Stacy McCoy; Sarah M Temkin; S Diane Yamada; Stacy T Lindau
Journal:  Cancer       Date:  2010-12-23       Impact factor: 6.860

4.  Predictors of sexual health in women after a breast cancer diagnosis.

Authors:  P A Ganz; K A Desmond; T R Belin; B E Meyerowitz; J H Rowland
Journal:  J Clin Oncol       Date:  1999-08       Impact factor: 44.544

Review 5.  The concept of erectile function preservation (penile rehabilitation) in the patient after brachytherapy for prostate cancer.

Authors:  Doron S Stember; John P Mulhall
Journal:  Brachytherapy       Date:  2012-02-11       Impact factor: 2.362

6.  Controlled prospective longitudinal study of women with cancer: I. Sexual functioning outcomes.

Authors:  B L Andersen; B Anderson; C deProsse
Journal:  J Consult Clin Psychol       Date:  1989-12

7.  Needs assessment survey to justify establishing a reproductive health clinic at a comprehensive cancer center.

Authors:  Eric Huyghe; Dawen Sui; Evan Odensky; Leslie R Schover
Journal:  J Sex Med       Date:  2008-09-24       Impact factor: 3.802

Review 8.  Prevention and management of postprostatectomy sexual dysfunctions. Part 1: choosing the right patient at the right time for the right surgery.

Authors:  Andrea Salonia; Arthur L Burnett; Markus Graefen; Kostas Hatzimouratidis; Francesco Montorsi; John P Mulhall; Christian Stief
Journal:  Eur Urol       Date:  2012-05-03       Impact factor: 20.096

Review 9.  Initial report of the cancer Patient-Reported Outcomes Measurement Information System (PROMIS) sexual function committee: review of sexual function measures and domains used in oncology.

Authors:  Diana D Jeffery; Janice P Tzeng; Francis J Keefe; Laura S Porter; Elizabeth A Hahn; Kathryn E Flynn; Bryce B Reeve; Kevin P Weinfurt
Journal:  Cancer       Date:  2009-03-15       Impact factor: 6.860

10.  Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues.

Authors:  M L Stead; J M Brown; L Fallowfield; P Selby
Journal:  Br J Cancer       Date:  2003-03-10       Impact factor: 7.640

View more
  9 in total

1.  A manifesto on the preservation of sexual function in women and girls with cancer.

Authors:  Stacy Tessler Lindau; Emily M Abramsohn; Amber C Matthews
Journal:  Am J Obstet Gynecol       Date:  2015-03-25       Impact factor: 8.661

2.  Finding sexual health aids after cancer: are cancer centers supporting survivors' needs?

Authors:  Sharon L Bober; Alexis L Michaud; Christopher J Recklitis
Journal:  J Cancer Surviv       Date:  2019-02-27       Impact factor: 4.442

Review 3.  How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer.

Authors:  Sharon L Bober; Jennifer B Reese; Lisa Barbera; Andrea Bradford; Kristen M Carpenter; Shari Goldfarb; Jeanne Carter
Journal:  Curr Opin Support Palliat Care       Date:  2016-03       Impact factor: 2.302

Review 4.  Physical examination of the female cancer patient with sexual concerns: What oncologists and patients should expect from consultation with a specialist.

Authors:  Stacy Tessler Lindau; Emily M Abramsohn; Shirley R Baron; Judith Florendo; Hope K Haefner; Anuja Jhingran; Vanessa Kennedy; Mukta K Krane; David M Kushner; Jennifer McComb; Diane F Merritt; Julie E Park; Amy Siston; Margaret Straub; Lauren Streicher
Journal:  CA Cancer J Clin       Date:  2016-01-19       Impact factor: 508.702

5.  Talking about women's sexual health after cancer: Why is it so hard to move the needle?

Authors:  Jennifer Barsky Reese; Sharon L Bober; Mary B Daly
Journal:  Cancer       Date:  2017-11-08       Impact factor: 6.860

6.  Sexual functioning among early post-treatment breast cancer survivors.

Authors:  Nancy E Avis; Aimee Johnson; Mollie Rose Canzona; Beverly J Levine
Journal:  Support Care Cancer       Date:  2018-02-17       Impact factor: 3.603

7.  Efficacy trial of an Internet-based intervention for cancer-related female sexual dysfunction.

Authors:  Leslie R Schover; Ying Yuan; Bryan M Fellman; Evan Odensky; Pamela E Lewis; Paul Martinetti
Journal:  J Natl Compr Canc Netw       Date:  2013-11       Impact factor: 11.908

8.  Female Sexual Health Training for Oncology Providers: New Applications.

Authors:  Lynn Y Wang; Annette Pierdomenico; Abbe Lefkowitz; Rachael Brandt
Journal:  Sex Med       Date:  2015-04-14       Impact factor: 2.491

9.  Investigating the impact of the COVID-19 pandemic on breast cancer clinicians' communication about sexual health.

Authors:  Jennifer Barsky Reese; Areej El-Jawahri; Kristen Sorice; Christina Cruz; Sharon L Bober; Mary B Daly; Lauren A Zimmaro; Mary Catherine Beach; Elaine Wittenberg; Antonio C Wolff; Elizabeth Handorf; Stephen J Lepore
Journal:  Support Care Cancer       Date:  2022-03-29       Impact factor: 3.359

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.